Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis
Translational Research · 2024
DOI: 10.1016/j.trsl.2024.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2024. Verfasst von Anni Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Fibrosis, Smad3 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a serious health problem worldwide, which ultimately leads to end-stage renal disease (ESRD). Renal fibrosis is the common pathway and major pathological manifestation for various CKD proceeding to ESRD. However, the underlying mechanisms and effective therapies are still ambiguous. Early growth response 2 (EGR2) is reportedly involved in organ formation and cell differentiation. To determine the role of EGR2 in renal fibrosis, we respectively confirmed the increased expression of EGR2 in kidney specimens from both CKD patients and mice with location in proximal tubules. Genetic deletion of EGR2 attenuated obstructive nephropathy while EGR2 overexpression further promoted renal fibrosis in mice subjected to unilateral ureteral obstruction (UUO) due to extracellular matrix (ECM) deposition mediating by partial epithelial-mesenchymal transition (EMT) as well as imbalance between matrix metalloproteinases (MMPs) and tissue inhibitor of MMPs (TIMPs). We found that EGR2 played a critical role in Smad3 phosphorylation, and inhibition of EGR2 reduced partial EMT leading to blockade of ECM accumulation in cultured human kidney 2 cells (HK2) treated with transforming growth factor β1 (TGF-β1). In addition, the transcription co-stimulator signal transducer and activator of transcription 3 (STAT3) phosphorylation was confirmed to regulate the transcription level of EGR2 in TGF-β1-induced HK2 cells. In conclusion, this study demonstrated that EGR2 played a pathogenic role in renal fibrosis by a p-STAT3-EGR2-p-Smad3 axis. Thus, targeting EGR2 could be a promising strategy for CKD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Nephrology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: drzhangchun@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Song, A., Yan, R., Xiong, W., Xiang, H., Huang, J., Jiang, A., & Zhang, C. (2024). Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis. Translational Research. https://doi.org/10.1016/j.trsl.2024.04.005
Vancouver
Song A, Yan R, Xiong W, Xiang H, Huang J, Jiang A, et al. Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis. Translational Research. 2024. doi:10.1016/j.trsl.2024.04.005
BibTeX
@article{Song2024,
author = {Song, Anni and Yan, Ruiwei and Xiong, Wei and Xiang, Huiling and Huang, Jing and Jiang, Anni and Zhang, Chun},
title = {Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis},
journal = {Translational Research},
year = {2024},
doi = {10.1016/j.trsl.2024.04.005}
}
EUVIMED